GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 907 filers reported holding GLAXOSMITHKLINE PLC in Q4 2021. The put-call ratio across all filers is 0.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | 0.0% | 266 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $12,000 | 0.0% | 266 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $12,000 | +20.0% | 266 | 0.0% | 0.01% | +20.0% |
| Q3 2021 | $10,000 | -9.1% | 266 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $11,000 | +22.2% | 266 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $9,000 | -10.0% | 266 | 0.0% | 0.01% | -16.7% |
| Q4 2020 | $10,000 | 0.0% | 266 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $10,000 | -9.1% | 266 | 0.0% | 0.01% | -14.3% |
| Q2 2020 | $11,000 | +10.0% | 266 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $10,000 | -16.7% | 266 | 0.0% | 0.01% | 0.0% |
| Q4 2019 | $12,000 | +9.1% | 266 | 0.0% | 0.01% | 0.0% |
| Q3 2019 | $11,000 | 0.0% | 266 | 0.0% | 0.01% | 0.0% |
| Q2 2019 | $11,000 | -50.0% | 266 | -50.0% | 0.01% | -50.0% |
| Q1 2019 | $22,000 | +10.0% | 532 | 0.0% | 0.01% | +7.7% |
| Q4 2018 | $20,000 | -4.8% | 532 | 0.0% | 0.01% | +8.3% |
| Q3 2018 | $21,000 | 0.0% | 532 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $21,000 | 0.0% | 532 | 0.0% | 0.01% | -7.7% |
| Q1 2018 | $21,000 | +10.5% | 532 | 0.0% | 0.01% | -7.1% |
| Q4 2017 | $19,000 | -13.6% | 532 | 0.0% | 0.01% | -17.6% |
| Q3 2017 | $22,000 | -4.3% | 532 | 0.0% | 0.02% | -5.6% |
| Q2 2017 | $23,000 | +4.5% | 532 | 0.0% | 0.02% | 0.0% |
| Q1 2017 | $22,000 | +10.0% | 532 | 0.0% | 0.02% | +5.9% |
| Q4 2016 | $20,000 | -13.0% | 532 | 0.0% | 0.02% | -19.0% |
| Q3 2016 | $23,000 | 0.0% | 532 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $23,000 | +4.5% | 532 | 0.0% | 0.02% | 0.0% |
| Q1 2016 | $22,000 | +4.8% | 532 | 0.0% | 0.02% | +5.0% |
| Q4 2015 | $21,000 | +5.0% | 532 | 0.0% | 0.02% | +5.3% |
| Q3 2015 | $20,000 | -9.1% | 532 | 0.0% | 0.02% | -5.0% |
| Q2 2015 | $22,000 | -12.0% | 532 | 0.0% | 0.02% | -9.1% |
| Q1 2015 | $25,000 | +8.7% | 532 | 0.0% | 0.02% | +10.0% |
| Q4 2014 | $23,000 | -99.8% | 532 | +204.0% | 0.02% | +122.2% |
| Q1 2014 | $9,350,000 | +0.1% | 175 | 0.0% | 0.01% | 0.0% |
| Q4 2013 | $9,343,000 | +6.4% | 175 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $8,780,000 | -36.1% | 175 | -36.4% | 0.01% | -40.0% |
| Q2 2013 | $13,742,000 | – | 275 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |